LSD and the Future of Medicine
Dr. Katrin Preller (University of Zurich) is in the midst of conducting the first-ever large scale controlled research study on the use of psychedelics for the treatment of depression and alcoholism. She and her colleagues believe that substances like LSD and psilocybin (“magic mushrooms”) not only present strong medical potential but could catalyze a paradigm shift in the way we approach mental health treatment entirely.
Be the first to hear from Katrin about some of the early experiences and results from this ongoing study, along with the personal experiences of Dr. Candace Lewis (TGen), who has herself directly experienced the treatment. This exploratory discussion will be moderated by Shannon Odell (The Science Channel), comedian, neuroscientist, and host of “Your Brain on Blank.”
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Candace Lewis
Translational Genomics Research Institute
Shannon Odell
Weill Cornell Medicine
Katrin Preller
University of Zurich